December 3, 2021

EU approves extra corona-vaccine sites for Pfizer, Moderna

Europe’s medicines regulator has authorised extra manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer-BioNTech and Moderna to assist enhance manufacturing amid a resurgence in infections, Reuters stories. The European Medicines Company in Amsterdam stated on Tuesday its human medicines committee had authorised a web site at Saint Remy sur Avre in France for making the Pfizer-BioNTech vaccine, Comirnaty.

Source link